1999Journal of HistotechnologyRequires access

Cervical Acid Phosphatase-Papanicolaou (CAP-PAP) Test

Olivera Marković, Nenad Marković, Mario Belledonne

Open publisher page 2 citations

Abstract

The high proportion of false negative results in cervical cancer screening and the lack of an inexpensive and rapid method for rescreening cervical smears led us to search for a way to maximize the detection of false negative cases. We describe a simple, rapid, and inexpensive procedure, the cervical acid phosphatase-Papanicolaou test (CAP-PAP test), that can alleviate the problem of false negatives. For research purposes, CAP-PAP test is immediately applicable in all laboratories currently doing the standard PAP test. It does not require special training for screeners or purchasing of additional expensive instruments. Additional cost per test is less than $1.00. The CAP-PAP test is compatible with automation. (The J Histotechnol 22:43, 1999)

About this research paper

What this paper is about

The high proportion of false negative results in cervical cancer screening and the lack of an inexpensive and rapid method for rescreening cervical smears led us to search for a way to maximize the detection of false negative cases. We describe a simple, rapid, and inexpensive procedure, the cervical acid phosphatase-Papanicolaou test (CAP-PAP test), that can alleviate the problem of false negatives. For research purposes, CAP-PAP test is immediately applicable in all laboratories currently doing the standard PAP test. It does not require special training for screeners or purchasing of additional expensive instruments. Additional cost per test is less than $1.00. The CAP-PAP test is compatible with automation. (The J Histotechnol 22:43, 1999)

Why it matters

OpenAlex reports 2 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

The high proportion of false negative results in cervical cancer screening and the lack of an inexpensive and rapid method for rescreening cervical smears led us to search for a way to maximize the detection of false negative cases. We describe a simple, rapid, and inexpensive procedure, the cervical acid phosphatase-Papanicolaou test (CAP-PAP test), that can alleviate the problem of false negatives. For research purposes, CAP-PAP test is immediately applicable in all laboratories currently doing the standard PAP test. It does not require special training for screeners or purchasing of additional expensive instruments. Additional cost per test is less than $1.00. The CAP-PAP test is compatible with automation. (The J Histotechnol 22:43, 1999)

Key concepts: Papanicolaou stain, Papanicolaou Test, Pap test, Cervical cancer, Medicine, Test (biology), Cervical cancer screening, Pap smears

Related papers

Back to paper searchBrowse research topicsOriginal source
Cervical Acid Phosphatase-Papanicolaou (CAP-PAP) Test — Research Paper | ScholarLens